111 (formerly New Peak Group), which runs an online retail drugstore and healthcare platform in China, filed on Wednesday with the SEC to raise up to $200 million in an initial public offering.
The Shanghai, China-based company was founded in 2010 and booked $182 million in revenue for the 12 months ended June 30, 2018. It plans to list on the NYSE under the symbol YI. 111 filed confidentially on May 17, 2018. J.P. Morgan, Citi and CICC are the joint bookrunners on the deal. No pricing terms were disclosed.
